$34.44
▲ +$0.86
(+2.56%)
Vol 616K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.5B
ROE
-1.9%
Margin
-1.0%
D/E
39.89
Beta
1.02
52W
$9–$34
Wall Street Consensus
16 analysts · Apr 20264
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
93.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 06, 2026
EPS Estimate: $0.09
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.09 | — | — |
| Dec 2025 | $0.10 | $0.07 | $-0.03 |
| Sep 2025 | $0.07 | $0.12 | +$0.05 |
| Jun 2025 | $0.06 | $0.12 | +$0.06 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $49.4M | $48.6M | $56.7M | $60.1M | $59.9M |
| Net Income | — | $450K | -$3.8M | $579K | $708K | -$13.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -4.4% | -4.4% | -4.4% | -1.9% | -1.9% | -1.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 1.0% | -2.3% | -2.3% | -1.0% | -1.0% | -1.0% |
| Gross Margin | 74.2% | 74.3% | 74.3% | 74.8% | 74.8% | 74.8% |
| D/E Ratio | 42.73 | 42.73 | 42.73 | 39.89 | 39.89 | 39.89 |
| Current Ratio | 4.14 | 4.14 | 4.14 | 4.09 | 4.09 | 4.09 |
Key Ratios
ROA (TTM)
-1.0%
P/S (TTM)
7.03
P/B
7.0
EPS (TTM)
$-0.05
CF/Share
$-0.46
Rev Growth 3Y
+13.7%
52W High
$34.24
52W Low
$9.22
$9.22
52-Week Range
$34.24
Financial Health
Free Cash Flow
$1.1M
Net Debt
$32.1M
Cash
$35.5M
Total Debt
$67.6M
As of Dec 31, 2025
How does AXGN compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
AXGN valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
7.0
▲
173%
above
peers
(2.6)
vs Peers
vs Industry
Overvalued
P/B ratio
7.0
▲
151%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
AXGN profitability vs Health Care peers
ROE
-1.9%
▲
95%
above
peers
(-38.5%)
vs Peers
vs Industry
Below avg
Net margin
-1.0%
▲
96%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
74.8%
▲
41%
above
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
-1.0%
▲
95%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
AXGN financial health vs Health Care peers
D/E ratio
39.9
▲
107%
above
peers
(19.3)
vs Peers
vs Industry
Above avg
Current ratio
4.1
▲
89%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
▼
3%
below
peers
(1.1)
vs Peers
vs Industry
Less volatile
AXGN fundamentals radar
AXGN
Peer median
Industry
AXGN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
AXGN vs peers: key metrics
Dividends
$1.10
/ year
Jan 27, 2010
$1.0000
Feb 23, 2005
$0.0600
Jul 10, 1992
$0.0417